Verition Fund Management
OMIC

Verition Fund Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Verition Fund Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,667
Closed -$257K – 3359
2024
Q1 		$257K Buy
16,667
+834
+5% +$12.7K ﹤0.01% 2378
2023
Q4 		$219K Hold
15,833
– – ﹤0.01% 1982
2023
Q3 		$181K Sell
15,833
-167
-1% -$3.1K ﹤0.01% 2003
2023
Q2 		$398K Buy
+16,000
New +$469K 0.01% 1362

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Verition Fund Management's OMIC Position: Q2 2024 in Review

Verition Fund Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 16,667 shares — an estimated $257K sold.

Verition Fund Management first reported a position in OMIC in Q2 2023 and held it in 4 quarters. The position peaked at $398K in Q2 2023. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Verition Fund Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Verition Fund Management sold 16,667 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $257K.
  • Verition Fund Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Verition Fund Management's Singular Genomics Systems, Inc. Common Stock position peaked at $398K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Verition Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.